{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:55:23Z","timestamp":1792842923267,"version":"4.5.0"},"reference-count":19,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,3,5]]},"DOI":"10.1248\/bpb.b25-00770","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T22:09:24Z","timestamp":1772662164000},"page":"452-456","source":"Crossref","is-referenced-by-count":1,"title":["Caspase-Independent Cell Death Induced by a Nitric Oxide Donor Derived from Valproic Acid in Human Pancreatic Cancer Cells"],"prefix":"10.1248","volume":"49","author":[{"given":"Koji","family":"Nishi","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"},{"name":"DDS Research Institute, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Ueda","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Beppu","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaho","family":"Takasaki","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Imoto","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"},{"name":"DDS Research Institute, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tsukikawa","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"},{"name":"DDS Research Institute, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Tokuno","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"},{"name":"DDS Research Institute, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Otagiri","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"},{"name":"DDS Research Institute, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"},{"name":"DDS Research Institute, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the monitoring of cancer incidence in japan (mcij) project. <i>Jpn. J. Clin. Oncol.<\/i>, <b>45<\/b>, 884\u2013891 (2015).","DOI":"10.1093\/jjco\/hyv088"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Bauer JA, Lupica JA, Didonato JA, Lindner DJ. Nitric oxide inhibits NF-\u03baB-mediated survival signaling:  possible role in overcoming trail resistance. <i>Anticancer Res.<\/i>, <b>40<\/b>, 6751\u20136763 (2020).","DOI":"10.21873\/anticanres.14698"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Nakato R, Ohkubo Y, Konishi A, Shibata M, Kaneko Y, Iwawaki T, Nakamura T, Lipton SA, Uehara T. Regulation of the unfolded protein response <i>via S<\/i>-nitrosylation of sensors of endoplasmic reticulum stress. <i>Sci. Rep.<\/i>, <b>5<\/b>, 14812 (2015).","DOI":"10.1038\/srep14812"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Theodosis-Nobelos P, Papagiouvanis G, Pantelidou M, Kourounakis PN, Athanasekou C, Rekka EA. Design, synthesis and study of nitrogen monoxide donors as potent hypolipidaemic and anti-inflammatory agents. <i>Molecules<\/i>, <b>25<\/b>, 19 (2019).","DOI":"10.3390\/molecules25010019"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Saavedra JE, Shami PJ, Wang LY, Davies KM, Booth MN, Citro ML, Keefer LK. Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: <i>in vitro<\/i> antileukemic activity. <i>J. Med. Chem.<\/i>, <b>43<\/b>, 261\u2013269 (2000).","DOI":"10.1021\/jm9903850"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Utispan K, Koontongkaew S. High nitric oxide adaptation in isogenic primary and metastatic head and neck cancer cells. <i>Anticancer Res.<\/i>, <b>40<\/b>, 2657\u20132665 (2020).","DOI":"10.21873\/anticanres.14236"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Korde Choudhari S, Chaudhary M, Bagde S, Gadbail AR, Joshi V. Nitric oxide and cancer: a review. <i>World J. Surg. Oncol.<\/i>, <b>11<\/b>, 118 (2013).","DOI":"10.1186\/1477-7819-11-118"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Huang Z, Fu J, Zhang Y. Nitric oxide donor-based cancer therapy: Advances and prospects. <i>J. Med. Chem.<\/i>, <b>60<\/b>, 7617\u20137635 (2017).","DOI":"10.1021\/acs.jmedchem.6b01672"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kashfi K, Rayyan Y, Qiao LL, Williams JL, Chen J, Del Soldato P, Traganos F, Rigas B. Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>303<\/b>, 1273\u20131282 (2002).","DOI":"10.1124\/jpet.102.042754"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Bonavida B, Khineche S, Huerta-Yepez S, Garb\u00e1n H. Therapeutic potential of nitric oxide in cancer. <i>Drug Resist. Updat.<\/i>, <b>9<\/b>, 157\u2013173 (2006).","DOI":"10.1016\/j.drup.2006.05.003"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Zaccara G, Messori A, Moroni F. Clinical pharmacokinetics of valproic acid--1988. <i>Clin. Pharmacokinet.<\/i>, <b>15<\/b>, 367\u2013389 (1988).","DOI":"10.2165\/00003088-198815060-00002"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. <i>J. Biol. Chem.<\/i>, <b>276<\/b>, 36734\u201336741 (2001).","DOI":"10.1074\/jbc.M101287200"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Aztopal N, Erkisa M, Erturk E, Ulukaya E, Tokullugil AH, Ari F. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells. <i>Chem. Biol. Interact.<\/i>, <b>280<\/b>, 51\u201358 (2018).","DOI":"10.1016\/j.cbi.2017.12.003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Jin X, Min Q, Wang D, Wang Y, Li G, Wang Z, Guo Y, Zhou Y. Fv-429 induces apoptosis by regulating nuclear translocation of pkm2 in pancreatic cancer cells. <i>Heliyon<\/i>, <b>10<\/b>, e29515 (2024).","DOI":"10.1016\/j.heliyon.2024.e29515"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. <i>Nat. Chem. Biol.<\/i>, <b>1<\/b>, 112\u2013119 (2005).","DOI":"10.1038\/nchembio711"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Fatokun AA, Dawson VL, Dawson TM. Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities. <i>Br. J. Pharmacol.<\/i>, <b>171<\/b>, 2000\u20132016 (2014).","DOI":"10.1111\/bph.12416"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Wang Y, Kim NS, Haince JF, Kang HC, David KK, Andrabi SA, Poirier GG, Dawson VL, Dawson TM. Poly(Adp-ribose) (Par) binding to apoptosis-inducing factor is critical for Par polymerase-1-dependent cell death (parthanatos). <i>Sci. Signal.<\/i>, <b>4<\/b>, ra20 (2011).","DOI":"10.1126\/scisignal.2000902"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kroemer G, Levine B. Autophagic cell death: the story of a misnomer. <i>Nat. Rev. Mol. Cell Biol.<\/i>, <b>9<\/b>, 1004\u20131010 (2008).","DOI":"10.1038\/nrm2529"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Satoh E, Yasuda I, Yamada T, Suzuki Y, Ohyashiki T. Involvement of no generation in aluminum-induced cell death. <i>Biol. Pharm. Bull.<\/i>, <b>30<\/b>, 1390\u20131394 (2007).","DOI":"10.1248\/bpb.30.1390"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/3\/49_b25-00770\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:01:49Z","timestamp":1772856109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/3\/49_b25-00770\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00770","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"article-number":"b25-00770"}}